de Boer M - Search Results

1

Thrombotic thrombocytopenic purpura related to ADAMTS13 deficiency, and successful treatment in a chimpanzee (Pan troglodytes verus).

van Bolhuis H, Wolters M, de Boer M, Fijnheer R, van Zijll Langhout M, Niphuis H, Eckmann C. van Bolhuis H, et al. Among authors: de boer m. J Med Primatol. 2017 Oct;46(5):267-270. doi: 10.1111/jmp.12278. Epub 2017 May 26. J Med Primatol. 2017. PMID: 28547839

2

Time to positivity of blood cultures supports early re-evaluation of empiric broad-spectrum antimicrobial therapy.

Lambregts MMC, Bernards AT, van der Beek MT, Visser LG, de Boer MG. Lambregts MMC, et al. Among authors: de boer mg. PLoS One. 2019 Jan 2;14(1):e0208819. doi: 10.1371/journal.pone.0208819. eCollection 2019. PLoS One. 2019. PMID: 30601829 Free PMC article.

3

Rifampin for Staphylococcal Prosthetic Joint Infection: Do We Still Need a Randomized Controlled Trial?

Scheper H, De Boer MGJ. Scheper H, et al. Clin Infect Dis. 2022 Apr 9;74(7):1316-1318. doi: 10.1093/cid/ciab704. Clin Infect Dis. 2022. PMID: 34402881 Free PMC article. No abstract available.

4

A new time-dependent approach for assessment of the impact of invasive aspergillosis shows effect on short- but not on long-term survival of patients with AML or high-risk MDS.

van de Peppel RJ, von dem Borne PA, le Cessie S, de Boer MGJ. van de Peppel RJ, et al. Among authors: de boer mgj. Bone Marrow Transplant. 2017 Jun;52(6):883-888. doi: 10.1038/bmt.2017.71. Epub 2017 May 15. Bone Marrow Transplant. 2017. PMID: 28504663

5

Implementation of a clinical decision rule for selecting empiric treatment for invasive aspergillosis in a setting with high triazole resistance.

van de Peppel RJ, van Grootveld R, Hendriks BJC, van Paassen J, Bernards S, Jolink H, Koopmans JG, von dem Borne PA, van der Beek MT, de Boer MGJ. van de Peppel RJ, et al. Med Mycol. 2021 Dec 8;60(1):myab060. doi: 10.1093/mmy/myab060. Med Mycol. 2021. PMID: 34878121 Free PMC article.

6

Distribution and clinical determinants of time-to-positivity of blood cultures in patients with neutropenia.

Lambregts MMC, Warreman EB, Bernards AT, Veelken H, von dem Borne PA, Dekkers OM, Visser LG, de Boer MG. Lambregts MMC, et al. Among authors: de boer mg. Eur J Haematol. 2018 Feb;100(2):206-214. doi: 10.1111/ejh.13001. Epub 2017 Dec 13. Eur J Haematol. 2018. PMID: 29171916

7

Helicobacter pylori resistance in the Netherlands: a growing problem?

Ruiter R, Wunderink HF, Veenendaal RA, Visser LG, de Boer MGJ. Ruiter R, et al. Among authors: de boer mgj. Neth J Med. 2017 Nov;75(9):394-398. Neth J Med. 2017. PMID: 29219812 Free article.

8

Early differentiation between uncomplicated and complicated Staphylococcus aureus bacteraemia: Potential value and limitations of a clinical risk score.

Lambregts MMC, Molendijk EBD, Meziyerh S, Schippers EF, Delfos NM, Leendertse M, Bernards AT, Visser LG, Dekkers OM, de Boer MGJ. Lambregts MMC, et al. Among authors: de boer mgj. Int J Clin Pract. 2020 Nov;74(11):e13601. doi: 10.1111/ijcp.13601. Epub 2020 Jul 14. Int J Clin Pract. 2020. PMID: 32603544 Free PMC article.

9

A more restrictive use of quinolones in patients with community acquired pneumonia is urgently needed.

Van Berge Henegouwen JM, Groeneveld GH, de Boer MGJ, Visser LG. Van Berge Henegouwen JM, et al. Among authors: de boer mgj. Neth J Med. 2017 Dec;75(10):462-463. Neth J Med. 2017. PMID: 29256421 Free article. No abstract available.

10

The Complex Case of Aspergillus and Mortality.

van de Peppel RJ, de Boer MGJ. van de Peppel RJ, et al. Clin Infect Dis. 2019 Jan 18;68(3):531-532. doi: 10.1093/cid/ciy698. Clin Infect Dis. 2019. PMID: 30165683 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,721 results

Search Page